STAT+: Don’t write off MDMA yet: How the FDA got on board with psychedelics
Psychedelic evangelists have been working to win over regulators since the 1980s, and those relationships helped persuade the FDA to sign off on research.
Days after an advisory committee resoundingly voted for the Food and Drug Administration to as medical treatment, the founder of the company that applied for approval” that the FDA would dismiss its advisers’ perspective and approve the first currently prohibited psychedelic come August, he said at the Interdisciplinary Conference on Psychedelic Research.
